RxDoctor Payments Data

Lydia Adams, APRN

Family Medicine · Fayetteville, TNNPI 1528618162

Payments from drug & device makers

$2,983in general payments, 2019–2025

Across 163 payments — averaging $18.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$387
  • Johnson & Johnson$254
  • Astellas Pharma US Inc$248
  • Novo Nordisk$236
  • Boehringer Ingelheim$236
  • Lilly USA, LLC$141
  • plus $1K from 31 others

What the payments were for

  • Food & beverage$2,983100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,983 in reported general payments places this provider in the 75th percentile of 2,087 family medicine providers in Tennessee.

See all family medicine providers in Tennessee

Medicare billing

Part B allowed, 2024
$40,493
Medicare patients
94
Services billed
914

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
VraylarCariprazine Hcl34$52,584
JardianceEmpagliflozin43$51,200
OtezlaApremilast17$42,281
OzempicSemaglutide30$38,102
EliquisApixaban38$30,856
Breztri AerosphereBudesonide/Glycopyr/Formoterol33$28,539
XareltoRivaroxaban26$28,203
JanuviaSitagliptin Phosphate29$25,429
RybelsusSemaglutide17$18,115
Trelegy ElliptaFluticasone/Umeclidin/Vilanter22$16,883
JanumetSitagliptin Phos/Metformin Hcl19$13,970
GemtesaVibegron24$13,393
FarxigaDapagliflozin Propanediol15$12,737
Spiriva RespimatTiotropium Bromide13$10,548
LinzessLinaclotide13$9,124

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieVraylar, Linzess, Synthroid$387$62,74661 claims
Boehringer IngelheimJardiance, Spiriva Respimat$236$61,74856 claims
Novo NordiskOzempic, Rybelsus$236$56,21747 claims
AmgenOtezla$14$42,28117 claims
AstraZenecaBreztri Aerosphere, Farxiga$13$41,27648 claims
MerckJanuvia, Janumet$115$39,39948 claims
PfizerEliquis$47$30,85638 claims
Johnson & JohnsonXarelto$254$28,20326 claims
Sumitomo Pharma America, Inc.Gemtesa$11$13,39324 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 2,087 family medicine providers in Tennessee.

Other family medicine in Fayetteville

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →